Monday, August 31, 2026

Stock Plummets 15% In Marathon Selloff On Friday

ViaNews Editorial Team

December 29, 2023

Stock Plummets 15% In Marathon Selloff On Friday

(VIANEWS) - Marathon (NASDAQ: MARA) stock fell by 15.19% at 12:23 EST on Friday, continuing its previous session's downward trend and following an overall market trend that saw the NASDAQ index decrease 0.77% to EUR14,979.06. Marathon's final closing price on that same day was EUR28.11 which was 1.37% above its 52-week high of EUR27.73.

About Marathon

Marathon Digital Holdings, Inc. is an industry-leading digital asset technology company specializing in mining digital assets for use within the blockchain ecosystem and generation in the United States. Formerly known as Marathon Patent Group Inc., Marathon Digital Holdings Inc was rebranded in February 2021 to reflect its focus on digital asset generation within America and was established in Fort Lauderdale Florida in 2010.

Yearly Analysis

Based on this data, Marathon's stock appears undervalued relative to its 52-week high; however, sales growth projections show considerable promise compared to last year (205.9% anticipated sales growth for 2017 vs 104% in 2016). Furthermore, Marathon's EBITDA margin is positive which shows they are producing profits. Given this information, investors may wish to purchase Marathon stock while it is undervalued and take advantage of its anticipated sales growth. However, investors must remember that past performance does not guarantee future outcomes and conduct additional research and analysis before making any investment decisions.

Technical Analysis

Marathon's stock has experienced an upward trajectory, as its current price of EUR22.56 surpasses both its 50-day and 200-day moving averages, which stand at EUR12.28 and EUR11.38 respectively. Furthermore, Marathon reported volume levels 74.7% higher than its usual 50426300 average volume volume -- indicative of strong buying interest among investors. Marathon has shown relatively high volatility over the past month, with an average intraday variation of 5.07% and highest amplitude of average volatility being at 7.00% in that same time period. Based on its stochastic oscillator, Marathon's stock is currently considered oversold (=20), suggesting it may be time for a price correction. Overall though, its overall bullish trend continues and investors may want to monitor Marathon's price movements over the coming days and weeks.

Quarter Analysis

Marathon's sales growth is indeed impressive, showing an astounding 342.5% increase for this quarter and an expected rise of 179.9% for next. Marathon also anticipates experiencing growth estimates of 90.6% in this and 180% in subsequent ones. Marathon's year-on-year quarterly revenue growth has outshone that of any competitor by 671.1% with current total of 259.16M for 12 trailing months. These impressive results demonstrate Marathon's robust revenue growth over the past year. Overall, investors should remain optimistic about Marathon's growth prospects given its strong sales and revenue expansion. However, before making any definitive investment decisions it is crucial to carefully evaluate other aspects such as profitability, competitive landscape and industry trends.

Equity Analysis

According to available data, Marathon's current earnings per share (EPS) stands at EUR-3.08 for its trailing twelve month earnings period; this indicates a negative EPS, suggesting the company isn't producing sufficient profits to provide adequate dividends to shareholders. Marathon's return on equity (ROE) for the past twelve months stands at negative -42.13%, suggesting that its profits aren't being generated efficiently and shareholders' equity isn't being utilized optimally to generate returns. Given these financial metrics, investors may wish to exercise extreme caution before investing in Marathon. Other considerations should include growth prospects, competitive landscape and overall market conditions before making an investment decision. It may be beneficial to consult a financial professional for a more in-depth evaluation of Marathon's financial health and investment potential.

More news about Marathon (MARA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com